Pronota Company
Pronota develops diagnostic devices for the early detection of conditions such as heart failure, pre-eclampsia and sepsis.
%20.jpg)
%20.jpg)
Founded Date:
18.10.2004
Last Funding Type:
Series C
Headquarters:
Ghent, Oost-Vlaanderen, Belgium
Investors Number:
10
Technology:
Cardiovascular Disorders Diagnostics
Employee Number:
11-50
Industry:
Deep Diagnostics
Estimated Revenue:
$1M to $10M
Funding Status:
Late Stage Venture
Total Funding:
$41.2M